Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology.
Vidal CI, Armbrect EA, Andea AA, Bohlke AK, Comfere NI, Hughes SR, Kim J, Kozel JA, Lee JB, Linos K, Litzner BR, Missall TA, Novoa RA, Sundram U, Swick BL, Hurley MY, Alam M, Argenyi Z, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Prieto VG, Robinson JK, Schaffer A, Subtil A, Wang WL. Vidal CI, et al. Among authors: litzner br. J Cutan Pathol. 2018 Aug;45(8):563-580. doi: 10.1111/cup.13142. Epub 2018 Jun 7. J Cutan Pathol. 2018. PMID: 29566273 Free article.
Muir-Torre syndrome appropriate use criteria: Effect of patient age on appropriate use scores.
Task Force/Committee Members; Vidal CI, Sutton A, Armbrect EA, Lee JB, Litzner BR, Hurley MY; Rating Panel; Alam M, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Robinson JK, Schaffer A. Task Force/Committee Members, et al. Among authors: litzner br. J Cutan Pathol. 2019 Jul;46(7):484-489. doi: 10.1111/cup.13459. Epub 2019 Apr 26. J Cutan Pathol. 2019. PMID: 30895633 Free article.
Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology.
Task Force/Committee Members; Vidal CI, Armbrect EA, Andea AA, Bohlke AK, Comfere NI, Hughes SR, Kim J, Kozel JA, Lee JB, Linos K, Litzner BR, Missall TA, Novoa RA, Sundram U, Swick BL, Hurley MY; Rating Panel; Alam M, Argenyi Z, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Prieto VG, Robinson JK, Schaffer A, Subtil A, Wang WL. Task Force/Committee Members, et al. Among authors: litzner br. J Am Acad Dermatol. 2019 Jan;80(1):189-207.e11. doi: 10.1016/j.jaad.2018.04.033. Epub 2018 Apr 22. J Am Acad Dermatol. 2019. PMID: 29689323
Reliability assessment and validation of the postacne hyperpigmentation index (PAHPI), a new instrument to measure postinflammatory hyperpigmentation from acne vulgaris.
Savory SA, Agim NG, Mao R, Peter S, Wang C, Maldonado G, Bearden Dietert J, Lieu TJ, Wang C, Pretzlaff K, Das S, Vandergriff T, Lopez IE, Litzner BR, Hynan LS, Arellano-Mendoza MI, Bergstresser PR, Pandya AG. Savory SA, et al. J Am Acad Dermatol. 2014 Jan;70(1):108-14. doi: 10.1016/j.jaad.2013.09.017. Epub 2013 Oct 28. J Am Acad Dermatol. 2014. PMID: 24176524
19 results